Consultations on new electronic formats for the product information of medicines are underway throughout Europe. An active participation in these consultations is possible by 31 July 2019, and commenting on the conception of "Electronic product information for human medicines in the EU – draft key principles" using an online form. You are invited to express your opinion.
The aim is to develop new standards for electronic product information ePI (electronic PI). Product information refers to the summary of product characteristics, the package leaflet, and the labels for the medicinal product. This includes improving readability, optimising navigation in the electronic information, and integrating a search. Only updated information which is also released by the competent authority shall be included.
The European Medicines Agency (EMA) ,the Heads of Medicines Agencies (HMA) and the European Commission (EC) invite you to an active participation. Patient organisations but also all interested individuals can participate.
Updated: 25.03.2019
